| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
36,010,000 |
| Market
Cap: |
543.03(M) |
| Last
Volume: |
129,261 |
Avg
Vol: |
128,904 |
| 52
Week Range: |
$9.69 - $21.36 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Orthofix Medical is a medical device company. Co.'s Global Spine segment provides implantable medical devices, biologics, and other regenerative solutions. This segment's product categories include: Bone Growth Therapies, which manufactures, distributes, and provides support services for bone growth stimulation devices; Spinal Implants, which designs, develops and markets a portfolio of motion preservation and fixation implant products; and Biologics, which provides a portfolio of products and tissue forms. Co.'s Global Orthopedics segment provides products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,500 |
7,500 |
| Total Buy Value |
$0 |
$0 |
$101,025 |
$101,025 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
8,243 |
12,505 |
| Total Sell Value |
$0 |
$0 |
$156,617 |
$232,268 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
3 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcmillan Bryan |
President, Spine GBU |
• – – |
2012-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
13,500 |
|
- |
|
| Finegan Michael |
President, Biologics |
• – – |
2012-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
23,860 |
|
- |
|
| Mccollum Brian |
Chief Financial Officer |
• – – |
2012-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
27,510 |
|
- |
|
| Trelles Vicente |
SVP, Worldwide Operations |
• – – |
2012-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
| Veters Robert S |
President and CEO |
• – – |
2012-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
64,367 |
|
- |
|
| Lee Brad |
President, Sports Medicine GBU |
• – – |
2012-05-03 |
4 |
S |
$40.45 |
$833,999 |
D/D |
(20,617) |
6,481 |
|
- |
|
| Lee Brad |
President, Sports Medicine GBU |
• – – |
2012-05-03 |
4 |
OE |
$23.58 |
$582,809 |
D/D |
20,617 |
27,098 |
|
- |
|
| Lee Brad |
President, Sports Medicine GBU |
• – – |
2012-05-02 |
4 |
S |
$40.37 |
$602,599 |
D/D |
(14,811) |
6,481 |
|
- |
|
| Lee Brad |
President, Sports Medicine GBU |
• – – |
2012-05-02 |
4 |
OE |
$23.58 |
$345,599 |
D/D |
14,050 |
21,292 |
|
- |
|
| Mainelli Michael |
Director |
– • – |
2012-02-02 |
4 |
A |
$24.65 |
$14,987 |
D/D |
608 |
1,919 |
|
- |
|
| Jordan Guy J |
Director |
– • – |
2012-02-02 |
4 |
A |
$24.65 |
$13,977 |
D/D |
567 |
1,256 |
|
- |
|
| Weisshaar Kenneth R |
Director |
– • – |
2012-02-02 |
4 |
A |
$24.65 |
$17,748 |
D/D |
720 |
2,031 |
|
- |
|
| Gero James |
Director |
– • – |
2012-02-02 |
4 |
A |
$24.65 |
$54,994 |
D/D |
2,231 |
131,294 |
|
- |
|
| Ferrari Luigi |
President, Orthopedics |
• – – |
2012-02-02 |
4 |
A |
$24.65 |
$43,014 |
D/D |
1,745 |
9,745 |
|
- |
|
| Mccollum Brian |
Chief Financial Officer |
• – – |
2012-02-02 |
4 |
A |
$24.65 |
$21,470 |
D/D |
871 |
10,763 |
|
- |
|
| Ferrari Luigi |
President,Orthopedics |
• – – |
2011-12-06 |
4 |
OE |
$28.95 |
$13,925 |
D/D |
481 |
481 |
|
- |
|
| Ferrari Luigi |
President,Orthopedics |
• – – |
2011-11-30 |
4 |
S |
$34.25 |
$727,436 |
D/D |
(21,239) |
0 |
|
- |
|
| Ferrari Luigi |
President,Orthopedics |
• – – |
2011-11-30 |
4 |
OE |
$23.58 |
$539,667 |
D/D |
21,239 |
21,239 |
|
- |
|
| Schumm Jeffrey |
General CounselOfficer |
• – – |
2011-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,625 |
|
- |
|
| Ferrari Luigi |
President, Orthopedics |
• – – |
2011-02-23 |
4 |
S |
$31.00 |
$53,971 |
D/D |
(1,741) |
8,000 |
|
- |
|
| Veters Robert S |
Executive VP & COO |
• – – |
2011-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
17,000 |
|
- |
|
| Ferrari Luigi |
President, Orthopedics |
• – – |
2011-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
8,000 |
|
- |
|
| Mccollum Brian |
Interim CFO |
• – – |
2011-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
9,892 |
|
- |
|
| Finegan Michael |
VP-Corporate Development |
• – – |
2011-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Milinazzo Alan |
President & CEO |
• – – |
2011-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
48,341 |
|
- |
|
697 Records found
|
|
Page 18 of 28 |
|
|
0.44 (3.01%) 
